BiomeSense

About:

BiomeSense is a developing novel technologies to enable continuous, at-home monitoring of the human microbiome.

Website: https://www.biomesense.com/

Twitter/X: BiomeSense

Top Investors: IndieBio, SOSV, National Science Foundation, IrishAngels, Bluestein Ventures

Description:

BiomeSense is developing the first technology platform for continuous, at-home monitoring of the human gut microbiome, transforming the ability to understand & utilize the microbiome for precision medicine. The enabling technology is the GutLab, the first “smart bathroom” system for at-home microbiome monitoring, which is combined with the MetaBiome time-series analytics platform into a single end-to-end solution. The platform allows scientists, patients, and consumers the unprecedented ability to tie microbiome changes directly to clinical outcomes in real time, revolutionizing the ability to leverage the microbiome for better health.

Total Funding Amount:

$12.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Chicago, Illinois, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)biomesense.com

Founders:

Jack Gilbert, Kevin Honaker, Savas Tay

Number of Employees:

1-10

Last Funding Date:

2023-12-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai